Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Biochemistry Research International|September 8, 2012
A novel Myosin essential light chain mutation causes hypertrophic cardiomyopathy with late onset and low expressivityPaal Skytt Andersen, Paula Louise Hedley, Stephen P Page, et al.
Circulation. Genomic and Precision Medicine|April 14, 2026
Yield of Postmortem Genetic Testing in Sudden Arrhythmic Death Syndrome: A Systematic Review and Meta-AnalysisEmanuele Monda, Sabrina Montuoro, Lia Crotti, et al.
Future Cardiology|September 23, 2017
Severe hypertrophic cardiomyopathy in a patient with atypical Anderson-Fabry diseaseDaniele Masarone, Giovanni Duro, Santo Dellegrottaglie, et al.
Journal of Cardiovascular Echography|June 19, 2018
Diagnostic Clues for the Diagnosis of Nonsarcomeric Hypertrophic Cardiomyopathy (Phenocopies): Amyloidosis, Fabry Disease, and Mitochondrial DiseaseGiuseppe Limongelli, Daniele Masarone, Marina Verrengia, et al.
Circulation. Genomic and Precision Medicine|December 4, 2023
Impact of GLA Variant Classification on the Estimated Prevalence of Fabry Disease: A Systematic Review and Meta-Analysis of Screening StudiesEmanuele Monda, Gaetano Diana, Francesca Graziani, et al.
Heart Failure Clinics|April 9, 2013
Takotsubo cardiomyopathy: do the genetics matter?Giuseppe Limongelli, Raffaella D'Alessandro, Daniele Masarone, et al.
JACC. Heart Failure|June 10, 2026
Genotype Predicts Heart Failure Independent of LVEF, Peak VO2, and NT-proBNP Levels in Hypertrophic CardiomyopathyAthanasios Bakalakos, Alexandros Protonotarios, Menelaos Pavlou, et al.
International Journal of Cardiology|July 16, 2019
Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathyGiuseppe Limongelli, Emanuele Monda, Stefania Tramonte, et al.
Circulation. Genomic and Precision Medicine|February 6, 2026
Cardiovascular Morbidity and Mortality in Fabry DiseaseEmanuele Monda, Athanasios Bakalakos, Annamaria Del Franco, et al.
Journal of the American College of Cardiology|November 11, 2025
Danicamtiv, a Selective Agonist of Cardiac Myosin, for Dilated Cardiomyopathy: A Phase 2 Open-Label TrialNeal K Lakdawala, Ray E Hershberger, Pablo Garcia-Pavia, et al.
Pageof 2